.webp)
Fermentation is the backbone of the bio-based economy. From food and cosmetics to chemicals and materials, it underpins many of the products we use every day. Yet despite major advances in synthetic biology, manufacturing cost remains the biggest barrier to large-scale adoption of bio-based alternatives to fossil-derived chemicals.
Traditional batch fermentation is slow, additive-heavy, and capital-intensive. Yield losses, downstream separation costs, and process inefficiencies prevent many promising bio-routes from ever becoming commercially viable.
DAB.bio was founded to remove this bottleneck.

We invested in DAB.bio because it delivers a step-change in fermentation economics, not a marginal improvement. Its patented FAST platform (Fermentation Accelerated by Separation Technology) enables continuous fermentation by integrating separation directly into the process. This dramatically increases productivity while cutting costs by 20–50% or more.
This directly aligns with our Climate Tech strategy: enabling scalable, cost-competitive alternatives to fossil-based production. DAB.bio stands out through its smart integration of proven technologies into a compact, industrially deployable system, rooted in world-class research from TU Delft.
Beyond capital, we have supported DAB.bio hands-on, from hiring and governance to follow-on financing, backing the team as it scaled from lab validation to industrial deployment.

DAB.bio is turning fermentation from a cost center into a competitive advantage: